IP News | IIPLA

News Archive

Fri, Oct 9, 20263 Tue, Oct 6, 20261 Mon, Oct 5, 20262 Thu, Oct 1, 20263 Wed, Sep 30, 20266 Tue, Sep 29, 20264 Mon, Sep 28, 20263 Sat, Sep 26, 20261 Fri, Sep 25, 20261 Thu, Sep 24, 202610

Latest IP news

Filtered news

News results

3 articles matching your filters, newest first.

Patentskorea

Korea and Japan Launch Continuous Intellectual Property Policy Cooperation After 45 Years

Korea Patent Attorneys Association and Japan’s Lawyers Society form working group to enhance bilateral IP systems and competitiveness

Marking a historic shift since 1981, Korea and Japan transition from annual intellectual property exchanges to a continuous policy cooperation framework. The Korea Patent Attorneys Association and Japan’s Lawyers Society have established a joint working group to address critical IP issues including finance, disclosure…

Wednesday, September 16, 2026

IIPLA News Desk

TrademarksGlobal

Samyang Foods' 'Buldak' English Trademark Clears Key Hurdle in Korea Amid Global Imitation Surge

Intellectual Property Office advances Samyang Foods’ English 'Buldak' trademark after expedited review, as company intensifies efforts to combat overseas counterfeiting.

Samyang Foods has achieved a significant milestone in its quest to secure domestic trademark rights for the English name 'Buldak,' following an expedited review by the Intellectual Property Office. The move comes as the company faces a proliferation of imitation products overseas and seeks to strengthen its global bra…

Tuesday, May 5, 2026

IIPLA News Desk

PatentsGlobal

Genprex Secures Key Japanese and European Patents for REQORSA Gene Therapy Combined with Immunotherapies in Cancer Treatment

Patents bolster Genprex’s global IP portfolio, supporting ongoing Acclaim-3 clinical trial for small cell lung cancer with PD-L1 and PD-1 antibody combinations

Genprex, Inc. has obtained favorable patent grants from the Japanese Patent Office and European Patent Office covering the use of its REQORSA gene therapy in combination with PD-L1 and PD-1 antibodies to treat cancer. These patents reinforce Genprex’s intellectual property rights in major markets and underpin its Accl…

Monday, February 23, 2026

IIPLA News Desk

Page 1 of 1

Newsroom tools

Subscribe to IIPLA Newsroom

Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.